Fujifilm Diosynth Biologics Facility

Holly Springs, North Carolina, United States

The Fujifilm Diosynth Biologics Facility in Holly Springs is a state-of-the-art biopharmaceutical manufacturing campus, representing the largest end-to-end cell culture CDMO facility in North America. Designed for scalable production of complex biologics and gene therapies, it features advanced process technologies and integrated operations. Strategically located in Holly Springs, North Carolina—a rapidly growing life sciences hub—the facility anchors the region’s biotech ecosystem and drives significant local economic impact. As of late 2025, the facility is newly opened, with ongoing expansion and strong market positioning as a global leader in biologics manufacturing.